CTOs on the Move

American Society of Anesthesiologists

www.asahq.org

 
The American Society of Anesthesiologists is an educational, research and scientific association of physicians organized to raise the standards of the medical practice of anesthesiology and to improve patient care.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million
  • www.asahq.org
  • 1061 American Lane
    Schaumburg, IL USA 60173
  • Phone: 847.825.5586

Executives

Name Title Contact Details

Similar Companies

YMCA of Greater Des Moines

Were for youth development, healthy living and social responsibility.

Acuity Medical Systems

Acuity Medical Systems is a Wayzata, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Wimbledon Health Partners

Wimbledon Health Partners formed in 2013 to meet the need for on-site diagnostic testing at physicians’ offices. The industry leader, Wimbledon Health Partners provides physicians with state-of-the-art, in-office testing to detect circulatory conditions using vascular ultrasound and electro- and echocardiography. Nerve conduction velocity testing is also used to support diagnosis of problems related to the nervous and muscular systems. Wimbledon Athletics, the newest division of Wimbledon Health Partners, is pioneering the way for high schools, colleges and universities to test students for unsuspected heart abnormalities to help minimize sudden cardiac death among young athletes.

Mercedes Medical Centers

Mercedes Medical Centers is a healthcare provider with a team of doctors, nurses, and caregivers who prioritize patient care and well-being. They have six medical centers located throughout Miami Dade County.

Immune Pharmaceuticals

Immune Pharmaceuticals applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company’s lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma. The Company is evaluating the use of its NanomAb® platform, a second generation antibody drug conjugate technology, with chemotherapeutics in order to enhance their safety and efficacy profiles by delivering the medicines directly to cancer cells. The Company’s growing oncology pipeline also includes proprietary antibodies and, clinical-stage small molecules that have been shown activity in a variety of solid tumors. Immune is headquartered in the U.S., with its primary research and development facilities in Israel.